Gan & Lee Pharmaceuticals Co., Ltd. Class ASSE: 603087

"Gan & Lee Pharmaceuticals."Announcement on Obtaining Notice of Approval for Drug Clinical Trials

Aug 25, 2026 · Issued by Gan & Lee Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Obtaining Notice of Approval for Drug Clinical Trials

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Gan & Lee Pharmaceuticals Co., Ltd. Class A

"Gan & Lee Pharmaceuticals"Announcement on the Listing and Trading of Certain Restricted Shares from the Initial Public OfferingAug 19
"Gan & Lee Pharmaceuticals"Announcement on Signing of the Authorization and License Agreement for the Bofanglutide Project with Menarini GroupAug 11
"Gan & Lee Pharmaceuticals"Announcement on Implementation of Repurchase and Cancellation of Certain Restricted Shares under the 2022 and 2024 Restricted Share Incentive PlansAug 8
"Gan & Lee Pharmaceuticals."Announcement on Shareholding Reduction Plan by Directors and Senior ManagementAug 7

All Gan & Lee Pharmaceuticals Co., Ltd. Class A news releases